Efficacy and Safety of Subcutaneous Secukinumab 150 mg with or Without Loading Regimen in Psoriatic Arthritis: Results from the FUTURE 4 Study
Crossref DOI link: https://doi.org/10.1007/s40744-019-0163-5
Published Online: 2019-06-21
Published Print: 2019-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kivitz, Alan J.
Nash, Peter
Tahir, Hasan
Everding, Andrea
Mann, Heřman
Kaszuba, Andrzej
Pellet, Pascale
Widmer, Albert
Pricop, Luminita
Abrams, Ken
Article History
Received: 26 April 2019
First Online: 21 June 2019